Get started
Arcadia Biosciences, Inc.Arcadia Biosciences, Inc.Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RKDA chart


Full chart

RKDA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.44 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.40 USD
Net income (FY)
‪−13.98 M‬ USD
Revenue (FY)
‪5.33 M‬ USD
Shares float
‪1.36 M‬
Beta (1Y)
1.90

Employees


Employees (FY)
21
Change (1Y)
−9 −30.00%
Revenue / Employee (1Y)
‪253.81 K‬ USD
Net income / Employee (1Y)
‪−626.67 K‬ USD

About Arcadia Biosciences, Inc.


Sector
Process Industries
CEO
Thomas J. Schaefer
Headquarters
Dallas
Website
arcadiabio.com
Founded
2002
FIGI
BBG000GYBX66
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RKDA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RKDA is 6.15 USD — it has increased by 1.48% in the past 24 hours. Watch Arcadia Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcadia Biosciences, Inc. stocks are traded under the ticker RKDA.
RKDA stock has risen by 6.92% compared to the previous week, the month change is a 118.37% rise, over the last year Arcadia Biosciences, Inc. has showed a 109.18% increase.
We've gathered analysts' opinions on Arcadia Biosciences, Inc. future price: according to them, RKDA price has a max estimate of 12.00 USD and a min estimate of 12.00 USD. Watch RKDA chart and read a more detailed Arcadia Biosciences, Inc. stock forecast: see what analysts think of Arcadia Biosciences, Inc. and suggest that you do with its stocks.
RKDA reached its all-time high on Jun 12, 2015 with the price of 7,040.00 USD, and its all-time low was 1.85 USD and was reached on Apr 15, 2024. View more price dynamics on RKDA chart.
See other stocks reaching their highest and lowest prices.
RKDA stock is 8.45% volatile and has beta coefficient of 1.90. Track Arcadia Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Arcadia Biosciences, Inc. there?
Today Arcadia Biosciences, Inc. has the market capitalization of ‪8.44 M‬, it has increased by 5.28% over the last week.
Yes, you can track Arcadia Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Arcadia Biosciences, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RKDA earnings for the last quarter are −1.18 USD per share, whereas the estimation was −0.81 USD resulting in a −45.68% surprise. The estimated earnings for the next quarter are −0.89 USD per share. See more details about Arcadia Biosciences, Inc. earnings.
Arcadia Biosciences, Inc. revenue for the last quarter amounts to ‪1.54 M‬ USD, despite the estimated figure of ‪1.40 M‬ USD. In the next quarter, revenue is expected to reach ‪1.15 M‬ USD.
RKDA net income for the last quarter is ‪−1.61 M‬ USD, while the quarter before that showed ‪1.06 M‬ USD of net income which accounts for −251.93% change. Track more Arcadia Biosciences, Inc. financial stats to get the full picture.
No, RKDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 21.00 employees. See our rating of the largest employees — is Arcadia Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arcadia Biosciences, Inc. EBITDA is ‪−9.40 M‬ USD, and current EBITDA margin is −241.67%. See more stats in Arcadia Biosciences, Inc. financial statements.
Like other stocks, RKDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcadia Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arcadia Biosciences, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arcadia Biosciences, Inc. stock shows the neutral signal. See more of Arcadia Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.